Cisco Finesse Web-based Management Interface Request cross site scripting

| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.8 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Cisco Finesse. It has been rated as problematic. This impacts an unknown function of the component Web-based Management Interface. The manipulation as part of Request leads to cross site scripting. This vulnerability is referenced as CVE-2019-15278. Remote exploitation of the attack is possible. No exploit is available. Upgrading the affected component is advised.
Details
A vulnerability was found in Cisco Finesse (version unknown). It has been rated as problematic. This issue affects an unknown function of the component Web-based Management Interface. The manipulation as part of a Request leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is confidentiality. The summary by CVE is:
A vulnerability in the web-based management interface of Cisco Finesse could allow an unauthenticated, remote attacker to bypass authorization and access sensitive information related to the device. The vulnerability exists because the software fails to sanitize URLs before it handles requests. An attacker could exploit this vulnerability by submitting a crafted URL. A successful exploit could allow the attacker to gain unauthorized access to sensitive information.
The weakness was published 01/26/2020 as cisco-sa-20200108-finesse-xss as confirmed advisory (Website). The advisory is shared at tools.cisco.com. The identification of this vulnerability is CVE-2019-15278 since 08/20/2019. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
Upgrading eliminates this vulnerability.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
License
Website
- Vendor: https://www.cisco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.8VulDB Meta Temp Score: 5.8
VulDB Base Score: 5.3
VulDB Temp Score: 5.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CNA Base Score: 6.1
CNA Vector (Cisco Systems, Inc.): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
08/20/2019 🔍01/26/2020 🔍
01/26/2020 🔍
03/26/2024 🔍
Sources
Vendor: cisco.comAdvisory: cisco-sa-20200108-finesse-xss
Status: Confirmed
CVE: CVE-2019-15278 (🔍)
GCVE (CVE): GCVE-0-2019-15278
GCVE (VulDB): GCVE-100-149345
Entry
Created: 01/26/2020 12:37Updated: 03/26/2024 09:20
Changes: 01/26/2020 12:37 (40), 01/26/2020 12:42 (11), 03/26/2024 09:20 (34)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.